» Articles » PMID: 1902808

Spontaneous Release of Interferon Gamma by Intestinal Lamina Propria Lymphocytes in Crohn's Disease. Kinetics of in Vitro Response to Interferon Gamma Inducers

Overview
Journal Gut
Specialty Gastroenterology
Date 1991 Apr 1
PMID 1902808
Citations 59
Authors
Affiliations
Soon will be listed here.
Abstract

The spontaneous induced release of interferon gamma (IFN gamma) by cultured intestinal lamina propria lymphocytes was investigated in patients with Crohn's disease. In contrast to normal lymphocytes, intestinal lymphocytes from these patients spontaneously released IFN gamma and seemed to contain IFN gamma in their cytoplasm. Autologous peripheral lymphocytes did not release IFN gamma. When stimulated with interferon inducers lamina propria lymphocytes from Crohn's disease tissue showed an increase in IFN gamma release 24 hours after induction with no appreciable further increase over the next two days of culture, while in control cells, either peripheral or intestinal, IFN gamma release progressively increased, peaking 72 hours after induction. These findings indicate that in Crohn's disease the intestinal lymphocytes are stimulated in vivo to produce IFN gamma and that the spontaneous IFN gamma production is compartmentalised to the gut lymphocytes. These data support the concept that locally released IFN gamma has a crucial role in cell interactions in the lamina propria and contribute to the locally occurring immune phenomena in Crohn's disease, including the increased epithelial expression of major histocompatibility complex class II antigens.

Citing Articles

Identification of a unique subset of tissue-resident memory CD4 T cells in Crohn's disease.

Yokoi T, Murakami M, Kihara T, Seno S, Arase M, Wing J Proc Natl Acad Sci U S A. 2022; 120(1):e2204269120.

PMID: 36574662 PMC: 9910620. DOI: 10.1073/pnas.2204269120.


Alteration of the Inflammatory and Anti-Inflammatory Cytokine Profiles of Peripheral Blood Mononuclear Cell in Crohn's Disease Patients after Following up.

Ghasemi F, Basirat V, Izad M, Tavassolifar M, Yaseri M, Ebrahimi Daryani N Iran J Public Health. 2022; 51(7):1648-1657.

PMID: 36248290 PMC: 9529721. DOI: 10.18502/ijph.v51i7.10099.


In vivo self-assembled siRNA as a modality for combination therapy of ulcerative colitis.

Zhou X, Yu M, Ma L, Fu J, Guo J, Lei J Nat Commun. 2022; 13(1):5700.

PMID: 36171212 PMC: 9519883. DOI: 10.1038/s41467-022-33436-0.


Effect of Crohn's disease mesenteric mesenchymal stem cells and their extracellular vesicles on T-cell immunosuppressive capacity.

Dadgar N, Altemus J, Li Y, Lightner A J Cell Mol Med. 2022; 26(19):4924-4939.

PMID: 36047483 PMC: 9549497. DOI: 10.1111/jcmm.17483.


IFN-γ mediates Paneth cell death via suppression of mTOR.

Araujo A, Safronova A, Burger E, Lopez-Yglesias A, Giri S, Camanzo E Elife. 2021; 10.

PMID: 34633285 PMC: 8570691. DOI: 10.7554/eLife.60478.


References
1.
Baker K, Jewell D . Cyclosporin for the treatment of severe inflammatory bowel disease. Aliment Pharmacol Ther. 1989; 3(2):143-9. DOI: 10.1111/j.1365-2036.1989.tb00200.x. View

2.
BULL D, Bookman M . Isolation and functional characterization of human intestinal mucosal lymphoid cells. J Clin Invest. 1977; 59(5):966-74. PMC: 372305. DOI: 10.1172/JCI108719. View

3.
Pallone F, Fais S, Capobianchi M . HLA-D region antigens on isolated human colonic epithelial cells: enhanced expression in inflammatory bowel disease and in vitro induction by different stimuli. Clin Exp Immunol. 1988; 74(1):75-9. PMC: 1541709. View

4.
Pallone F, Fais S, Squarcia O, Biancone L, Pozzilli P, Boirivant M . Activation of peripheral blood and intestinal lamina propria lymphocytes in Crohn's disease. In vivo state of activation and in vitro response to stimulation as defined by the expression of early activation antigens. Gut. 1987; 28(6):745-53. PMC: 1433036. DOI: 10.1136/gut.28.6.745. View

5.
Mayer L, Shlien R . Evidence for function of Ia molecules on gut epithelial cells in man. J Exp Med. 1987; 166(5):1471-83. PMC: 2189639. DOI: 10.1084/jem.166.5.1471. View